Αποτελέσματα Αναζήτησης
Younger age (40-49 years, OR = 8.14 [1.35-49.13]) and nonsmoking (OR = 5.39 [1.48-19.65]) predicted recovery from HLH. Men with iHLH developed erectile dysfunction, poor health, cardiovascular disease (CVD) and cancer more frequently than pNLH men.
5 Οκτ 2017 · The interpretation of a testosterone level found to be low on a sample taken at 09.00, requires a serum prolactin, LH and FSH measurement in order to rule out secondary hypogonadism. Also, sex hormone binding globulin (SHBG) measurement may help.
23 Νοε 2023 · Diagnosing imbalances in Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) is a critical step in addressing the complex issues related to male hormonal health. The process involves a combination of clinical assessments, detailed medical histories, and specific laboratory tests.
In this study, most men above the age of 40 years experienced the symptoms of hypogonadism and the majority of the symptoms were related to psychological domain. The score of the symptoms in this domain had no association with serum levels of total and free testosterone.
In patients with signs and symptoms indicative of hypogonadism, determining luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels together with the initial testosterone level is usually most efficient.
men with genuine age-related (primary) hypogonadism, characterised by raised LH levels. Thus, the term LoH may be better reserved for older men with otherwise unexplained primary gonadal insufficiency. Although the incidence of primary hypogonadism in men is low (0.2%/year), it increases with both age and chronic illness (7, 8).
9 Ιαν 2020 · An observational, retrospective, big data trial was carried out, including all testosterone, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) measurements performed in a single laboratory between January 2010 and January 2019 using Chemiluminescent Microparticle Immunoassay.
